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The suicidal behavior is regarded as the act by which a person seeks to take his life, being aware 
of the consequences of his action. In our review, besides describing the main introductory 
aspects for the concept of suicide, we focus our attention on the main neurophysiological 
and genetical mechanisms relevant for this extremely difficult to manage and controversial 
behavior. Moreover, considering the latest interests in the current literature on the relevance 
of central oxytocin to various superior cognitive behaviors, we will also make a short 
description on how important effects of oxytocin could be in the context of suicidal behavior.
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INTRODUCTION 
THE CONCEPT OF SUICIDE
The suicidal behavior is regarded as the act by which 
a person seeks to take his life, being aware of the 
consequences of his action [1]. Thus, suicide can be 
regarded as a rationally executed act, based on moral, 
social, religious, philosophical and/or personal reasons. 
Conversely, suicide may be seen as a pathological 
act, which occurs during the development of various 
mental disorders (e.g., depression, persistent delirium, 
dementia, confusion, etc.), or in the context of an acute 
existential crisis in which the manifestations may 
take the form of an auto-aggressive anxious raptus. 
These raptuses are spontaneous, unpredictable, and 
are manifested extremely rapidly, as compared with 
the premeditated suicide of patients with melancholic 
depression or in the context of systematized deliria [2]. 
Overall, regardless of motivations and context (e.g., 
social, family, or personal), the concept of suicidal 
ideation refers to a person’s thoughts to take his/her 
own life.
The World Health Organization defines suicide as an 
act by which an individual seeks for his/her physical 
self-destroy, with the more or less authentic intention 
to waste his/her life or being more or less conscious 
of the rationale of the gesture [3]. Interpreted more 
broadly, the concept of suicide can also refer to any 
action, tendency, or behavior of self harm (including 
the so-called “chronic suicide “ of drug addicts, 
alcoholics, or individuals with mental anorexia) that 
by certain self-destructive behaviors of repetitive 
cyclical-nature attempts to finish the personal life. 
Also, in a narrow interpretation, the suicide is the act 
of global self-destruction, of sudden suppression of 
one’s own life, intentionally, willfully, knowingly, and 
considering death as a total and inexorable ending.
In fact, suicide is the expression of an acute crisis 
of conscience that expresses a subjective-affective 
tension between the individual and the group, favored 
by situational factors, with the ability to precipitate 
the autolytic gesture in a fragile and vulnerable 
personality [4]. In this way, Douglas [5] defines 
suicide from a double perspective, both psychological 
and sociological, addressing rather a concept than 
an operational definition. Douglas reveals the five 
dimensions of the suicidal act, namely initiative, 
motivation, intention, will, and desire. According 
to Scripcaru et al. [6], the suicide definition would 
represent a tempted or actual behavior expressing a 
psycho-emotional tension between the individual 
and the social group, triggered or precipitated by 
circumstantial factors with a consciously designed 
self-destruction idea. In addition, other theorists 
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consider suicide a disruption of homeostasis in the 
individual/environmental relation and deciphering its 
code depending on the visibility and understandability 
of its forms of expression. Thus, in some individuals 
a death will is certain, while in others it is uncertain, 
in some it is impulsive, in some it can be cyclical, in 
some it is chronic, persistent, and in others the wish to 
die is acute, transient, with or without a repeatability 
trend.
The concept of suicidal behavior refers to the 
technical support, consisting of the preparatory work 
for staging the suicidal act, the steps and settling 
the suicidal plan. Choosing the manner of ending 
one’s own life is determined by many factors, such 
as effectiveness, speed, ease of execution, imitation, 
keeping physical appearance and bodily integrity, 
availability of the suicidal method, and sometimes 
also by limiting as much as possible the beforehand 
suffering and anguish. To ensure the success of the 
method, the most efficient approach will be adopted 
in accordance with the availability and access to 
certain types of methods. But ultimately, the choice of 
the suicidal means is determined by the significance 
of the act and the mental condition of the person at 
the time when committing suicide. The effectiveness 
of the chosen means is regarded as revealing the 
authenticity of the suicide attempt. Traditionally, 
it is considered that the main autolytic means are 
traumatic (defenestration and shooting), asphyxia 
(gas inhalation, submersion, strangulation), and toxic 
(ingestion of the respective substances) [7].
Also, certain aspects due to cultural differences 
should be mentioned when choosing other variants 
of self harm. Thus, while in China the poisoning 
with opium and salts of arsenic is frequent, in Japan 
the traditional seppuku was replaced by the use 
of firearms, while in France the order of the most 
commonly used methods is hanging, drowning, and 
using firearms [8].
Below, we will briefly review the main methods 
used in suicidal behavior. One such method involves 
exsanguination by damaging the easy to access 
arteries (radial, ulnar, carotid, or femoral), wich 
causes hypovolemia below the critical level leading 
to a circulatory collapse. Chronic suicide attempts, 
parasuicide, or self-mutilation attained in the same 
manner can be assessed by looking for traumatic 
marks (scars) at the level of these arteries. Also 
typical of this type of conduct is a large number of 
injuries [9]. In addition, suicide by hanging involves 
two types of mechanisms, depending on the length of 
the drop. Thus, one of the mechanisms that occurs in 
the short drop achieves death by hypoxia through the 
compression of the carotid artery and jugular vein. For 
the longer drops, vertebral fractures can occur, often in 
the C5-C6 vertebrae, which cause death or paralysis in 
the survivors [10].
Another autolytic method used by suicidal persons 
is by jumping from high buildings, through windows 
(defenestration), from bridges or cliffs. This is frequent 
especially in the areas with increased accessibility to 
these kind of methods. For example, in Hong Kong, 
where there are a large number of high buildings, more 
than half of the deaths by suicide are executed through 
this method [11]. This autolytic approach is associated 
with a high risk of severe consequences in the case 
of a failed suicide, such as paresis, paralyses, bone 
fractures, and severe damages to internal organs.
Another method of suicide used relatively frequently 
involves the use of firearms. The use of firearms 
in suicide attempts is more common in people who 
routinely possess firearms, but also in countries with 
permissive legislation on firearms possession [12]. 
However, it is doubtful to believe that the legislative 
restrictions concerning the firearms possession would 
lead to lower overall rates of suicide. The decrease 
of certain methods of suicide by reducing the access 
possibilities could lead to increased rates of other 
types of methods as a compensatory mechanism.
Suicide produced by asphyxia is often achieved 
by exposure to certain toxic gases, such as carbon 
monoxide. This produces a quick death as it rapidly 
induces unconsciousness state preventing an eventual 
change of mind of the suicidal person [13].
Suicide by drowning is relatively rare, as compared 
to other autolytic methods. A study conducted on the 
US population reported less than 2% of suicide deaths 
as caused by drowning. The mechanism of death 
consists in the acute oxygen deprivation of the brain 
by immersion in water that impedes the breathing 
process.
Other common suicidal methods include drug 
overdose, traffic accidents, electrocution, or poisoning. 
Also, as previously mentioned, the modern trend 
concerning the growing use of hallucinogens suggests 
that drug addiction can be a passive form of self-
distructive behavior. The chronic use of hallucinogens, 
naturally, has strong negative consequences on health. 
Very interestingly, a research on the places selected 
for accomplishing the suicide reported that about 44% 
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of suicidal acts are performed at home; public places; 
hotels, and working places are less preferred [14]. In 
this way, such aspects could represent an important 
lead when intending to oversee and prevent a person 
known with a high risk of suicide.
According to Stengel [15], the genuine suicidal act 
unfolds as follows: the occurrence of one’s decision to 
end his/her lives or the impulsive action to self-kill, 
using for this the most efficient methods and taking all 
the safety measures that nobody will interfere. If death 
occurs, it is considered a successful suicide attempt; 
if the person survives, the act would be considered a 
failed suicide one. As death is the only purpose of the 
act, it should be considered the criterion for success. 
The failure may be caused by any of the following: 
motivation is not strong enough; the act has not been 
well prepared (either due to lack of total conviction on 
completing the act, or because of lack of knowledge on 
the limits of the chosen method, lack of judgment, and 
determination because of a mental illness). According 
to these criteria, only a part of the accomplished 
suicidal acts and only a small part of those unfinished 
can be considered genuine acts of suicide. However, 
even in the suicidal acts where the person is not fully 
committed to end his life, a significant number of 
cases come to completion, while the rest remain as 
unclear trends or insufficient efforts, ending rather by 
accident than by determination in action.
In this way, it could be stated that suicide is actually 
the action of taking one’s own life, while a suicide 
attempt or non-fatal suicidal behavior refers to self-
harming in order to take one’s own life, but that does 
not lead to death. The differences between assisted 
suicide and euthanasia, types of suicide that require 
another person in order to be completed, should also 
be mentioned. The assisted suicide occurs when a 
person indirectly helps another to end his/her life, by 
providing advices or means for the suicidal act, and it 
differs from euthanasia, in which the other person is 
playing a more active role in causing someone’s death.
In most cases, the completed suicide follows 
repeated suicide attempts. A large number of patients 
who died by suicide have a history of autolytic 
suicide attempts or even suicidal ideation. Sometimes, 
the suicidal people have in their family relatives 
with suicide attempts or completed suicide, which 
may account for models in their autolytic behavior. 
Attempted suicide is actually the missed (failed) 
suicidal act. The attempts may be the expression 
of a compulsion, can have a demonstrative value, 
or embody the expression of a punitive act. In fact, 
clinical studies have shown that suicidal attempts are 
8-10 times more common in young people than in 
adults and about 5-10 times more often in women than 
in men, the ratio decreasing with age [16].
In general, the suicidal tendencies are explained by 
self-aggression, and the suicidal impulse explains the 
suicide as an expression of an irresistible trend. The 
irresistible suicidal impulse drives the individual to 
make use of the first means he/she comes across, in 
opposition to the former suicide plan. Often, the suicide 
attempts leave long-term physical consequences, 
which can be very different depending on the autolytic 
method. Thus, some serious physical sequelae may 
occur following autolytic attempts, such as mutilation, 
fractures, severe locomotor, psycho-sensorial, or 
mental disabilities (e.g., dementia after oxygen 
deprivation), or functional disabilities (paralysis).
In this way, Biberi [17] considers the suicide 
as a bio-psycho-social dimensional phenomenon 
representing an act requiring the deviation for one 
of the most deeply rooted instinct of the biological 
structure. In a dramatic situation in which the vital 
instinct is denied (out of which the subject does not 
see any escape), suicide becomes the only solution to 
avoid its unbearable conditions.
Also, according to Menninger [18], the suicide 
encompasses the three desires that could foster a 
suicidal act, namely the desire to kill, the desire to be 
killed, and the desire to die. The desire to kill may be 
directed not only against an object of love, but also 
against the internal space. In fact, the conclusions of 
some long-term clinical trials showed that suicide is 
sometimes intended to destroy the lives of survivors, 
as an act of revenge against the others. For example, 
depressed patients often feel that suicide is the only 
satisfactory revenge. Sometimes, this act is directed 
against the parents, brothers, or the partner, and the act 
is intended to produce suffering of the latter.
In other cases, aggression plays a much more 
modest role in terms of motivating the suicide. Thus, 
Fenichel [19] noted that suicide could mean the 
fulfillment of a desire to reunite. Losing a loved one 
is often behind suicidal behavior, and many suicidal 
patients exhibit strong desires of dependence on the 
lost person. From this point of view, the suicide may 
be a regressive desire to reunite with a lost figure. 
Sometimes, a pathological process of mourning is 
involved, especially in attempts to commemorate the 
death of a loved one. In this way, there are some ideas 
that it could be a correlation between suicide and the 
commemoration for the death of a parent.
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EPIDEMIOLOGICAL ASPECTS
The suicidal behavior is considered a psychiatric 
emergency. Virtually, all psychiatric disorders can 
sometimes generate either spontaneous auto-aggressive 
and hetero-aggressive outbursts on a background 
of high psychoemotional tension or, by contrary, 
planned and idealized previously of the act. The 
demographic analysis of the completed suicide shows 
that, generally, the chosen suicide method depends on 
the geographical area and availability of the method, 
but also on certain personal factors. Among the chosen 
suicide methods, the most commonly used seems to be 
hanging, probably due to the easy access to material, 
as compared to other methods. A study conducted in 
56 countries found hanging as the prevailing method 
of suicide in most countries [20]. This method was 
employed by 53% of men and 39% of women [21].
Also, a relatively high number of suicides have 
been recorded as a result of drug overdose, the cause 
of about 60% of the suicide cases in women and 30% 
in men [22]. Frequently, the suicide by overdose is 
not previously planned, or it occurs during a period 
of acute ambivalence. The difference between sexes 
regarding this method supports the idea of a higher 
frequency of planned suicide in men. The most often 
tried methods differ from the most often successful 
methods; up to 85% of suicide attempts in the 
developed countries consist in ingesting an overdose 
of drugs [23].
Moreover, the studies are generally indicating 
different percentages regarding the type of suicidal 
methods. A meta-analysis concerning the most frequent 
suicide methods identified shooting in 80-90% cases, 
drowning 65-80%, inhalation of an exhaust gas 40-
60%, jumping from height 35-60%, and pesticides 
6-75% [24].
Also, a regional analysis of the methods and 
frequency of suicide methods showed that, 57% 
of suicides in the United States, involve the use of 
a firearm, the percentage being distinctly higher in 
men than in women. A second cause of suicide in 
men is hanging, while in women this is poisoning. 
In Switzerland, the most common suicidal method is 
the suicide by hanging [25], while in Hong Kong and 
Singapore, suicide by jumping from height is very 
common, with rates ranging from 50% in Hong Kong 
to 80% in Singapore [24]. Moreover, in Japan, suicide 
by hanging is the most common method [26], but also 
the traditional suicide by disembowelment known as 
seppuku, or harakiri, is still used nowadays.
NEUROPHYSIOLOGICAL MECHANISTICS 
AND THEORIES OF SUICIDE
In this way, among the most investigated biologi-
cal systems related to the suicidal behavior is the se-
rotonergic system. The researches focused on the 
levels of serotonin, its metabolite (5-hydro xy-
indoleacetic acid, 5HIAA), its receptors (5HT2A), and 
its carrier (5HTT) in platelets. There are also several 
studies that have compared the whole blood- or plate-
let- levels of 5HT in patients with mood disorders and 
a suicide risk. Thus, Roggenbach et al. and the group 
led by Mann [35, 36] reported decreased serotonin 
levels in blood platelets in suicidal patients with real 
suicide attempts, as compared to patients with suicid-
al ideation only or without autolytic attempts and also 
non-suicidal patients.
Also,  Almeida-Montes et  al .  [37] reported 
significantly decreased serum levels of 5HT in 
depressed patients who attempted suicide, when 
compared with depressed patients without suicide 
attempts. Moreover, in a meta-analysis by Lester [38] 
on a CSF serotonin metabolite, the authors found 
significantly lower levels of 5HIAA in the patients 
with previous suicide attempts, as well as in those who 
subsequently committed suicide or attempted this. In 
addition to low CSF 5-HIAA levels, the persons who 
committed suicide showed also an increased number 
of binding sites for serotonin. In terms of the autolytic 
ideation intensity, Tyano et al. [39] also found a 
negative correlation between plasma levels of 5HT and 
the severity of suicidal behavior in patients.
In addition, determining the 5HT receptors in 
suicidal patients or those with affective disorders 
led to the extensive study of the 5HT2A receptor. In 
this way, the 5HT2A receptor seems more likely to 
be modified in patients with depressive disorders and 
suicidal ideation. In general, the 5HT2A receptors 
were examined in blood platelets by radioligand 
binding techniques, and the pharmacological profile 
of the 5HT2A receptors in the platelets appears to be 
very similar to that observed in the brain [39].
Even more, Pandey and his collaborators [40] 
studied the platelet levels of 5HT2A receptors in 
patients with affective disorders with and without 
autolytic ideation. In the first instance, the level of 
5HT2A receptors was found to be higher in depressed 
patients, as compared with control subjects. Also, the 
5HT2A receptor density was even higher in depressed 
patients with suicidal behavior, when compared to 
depressed patients without suicidal ideation. When 
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analyzing whether the increase of the 5HT2A receptors 
in the depressed suicidal patients is independent or 
not diagnostic and by examining the 5HT2A receptor 
levels in patients with various psychiatric diagnoses 
(such as depression, bipolar depression, manias, 
schizoaffective disorder, or schizophrenia), the authors 
also noted that the average receptor density in the total 
group of suicidal patients was significantly higher than 
that in non-suicidal patients or in the control group. 
Also, the receptor density was significantly higher in 
the patients with psychiatric disorders and autolytic 
ideation, as compared with control subjects. In 
addition, this study [40] suggested the increase of the 
platelet 5HT2A receptor density in suicidal patients, 
irrespective of the diagnosis.
In addition, numerous evidences supported the 
involvement of the 5-HT1A receptor in the formation 
of suicidal behavior. The important role of 5-HT1A 
receptors in suicidal behavior was in this way assayed 
by studying the changes of these receptors in the 
postmortem brains of the suicide victims. In this 
way, the results showed that binding to the 5-HT1A 
receptors was found to increase in the cortex of 
suicidal patients with major depression, but no change 
in binding to these receptors was observed in the 
frontal lobes, occipital cortex, hippocampus, and 
amygdala of depressed suicidal patients [41, 42]. These 
discrepancies could be explained by the intervention 
of other factors, such as gender, presence or absence 
of affective disorders, or ethanol consumption (as we 
would like to insist immediately on this important 
factor).
Also, the involvement of the serotonergic system 
in suicidal behavior seems to correlate with specific 
nervous areas, such as the forebrain, medial prefrontal 
cortex, orbitofrontal cortex, amygdala, and nucl. 
accumbens [43]. In this way, the postmortem studies of 
suicidal persons reported fewer serotonin transporters 
in the prefrontal cortex, hippocampus, occipital cortex, 
and brainstem [44].
We should also mention that the relationship 
between serotonin and aggressiveness [45] is an 
important aspect in studying the neurobiological 
underpinnings of suicide, especially in violent suicide 
cases. In fact, suicidal behavior is influenced by many 
biological variables that modify the serotonergic 
neurotransmission, including the psychosocial stress, 
traumatic experiences, pathological personality traits, 
disorders, or the alcohol abuse [46, 47].
Regarding the latter mentioned aspect, it is well 
known that alcoholism can be found in most psychiatric 
disorders and is often having an etiopathogenic 
role. Thus, affective disorders, anxiety, psychosis, 
dementia, and personality disorders frequently 
are accompanied by alcoholism as a co-morbidity. 
Moreover, some mental disorders are caused by 
prolonged or abusive alcohol consumption; other 
disorders appear as withdrawal phenomena, while 
in many cases alcoholism aggravates a preexisting 
psychiatric conditions. In some cases, alcohol 
consumption is intended to improve the psychiatric 
symptoms, such as anxiety, depression, psychosis, 
hypnic disorders, or side effects of medications [48]. 
Among the psychiatric disorders, depression and mood 
disorders are particularly associated with alcohol 
abuse. Of course, patients suffering from a major 
depressive disorder are at increased risk of suicide. 
What is important in the present context, is that 
studies on patients who died by suicide showed that in 
30% of cases the blood alcohol level was close to or 
over the legal limit at the time of suicide, and half of 
them suffered from major depression [49]. Moreover, 
alcohol abuse is also suspected to dramatically (by 
an order of magnitude) increase the risk of suicidal 
behavior [50].
Sti l l ,  the relat ionship between alcoholism, 
depression, and suicidal behavior is complex 
and clearly supported on the biochemical level. 
Some CSF analysis showed abnormalit ies of 
serotonin metabolism, through the dosing of the 
5-hydroxyindoleacetic (5HIA) metabolite in depression 
and particularly in suicidal behavior. Moreover, low 
levels of this serotonergic metabolite are encountered 
in impulsivity and aggressive excesses, which are 
manifested especially during the consumption of 
ethanol. As was many times mentioned, the elements 
of impulsivity and aggression are known to correlate 
with suicidal behavior [51].
Moreover, the risk of suicide for the patients 
addicted to alcohol is 60 to 120 times higher than that 
in the general population [52]. The gender distribution 
shows also a much higher frequency in men, in 
relation to the use of alcohol before committing the 
suicidal act [53]. Also, alcohol consumption can cause 
disinhibition and increased impulsivity, which could 
favor mobilization to complete the suicidal act.
GENETIC STUDIES
With regard to suicidal behavior, the research on 
families, twins, and adoptions provided evidence 
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on the significant heritability of suicide and suicide 
attempts, independent of the family transmission for 
the major psychiatric disorders. Thus, for twins the 
estimated heritability for suicidal risk ranges between 
21-50%, while for the broader phenotype of suicidal 
behavior (attempts, suicidal thoughts, and plans) it is 
30-55%, depending on the type of study [27]. Also, 
some genetic researches have attempted to identify 
the genes involved in suicide and suicidal behavior 
by studies of genetic association or following specific 
single nucleotide polymorphisms for studies of 
association.
Candidate genes for association studies were gener-
ally selected on the basis of evidence from neurobio-
logical studies in suicidal patients. Therefore, the se-
rotonergic system has been extensively investigated in 
relation with other target systems, including the dopa-
minergic and noradrenergic ones, derived neurotrophic 
factor, and, more recently, the genes related to hypo-
thalamic-pituitary-adrenal (HPA) axis. Apparently, the 
environment could be also very influential in this mat-
ter, especially during the development.
Moreover, the neurobiological evidences indicated 
a considerable serotonergic dysfunction in suicide 
cases, while the genetic research has been mainly 
focused on genes related to the serotonin system. At 
the molecular level, serotonin appears to be one of 
the key neurotransmitters involved in the formation 
and control of suicidal behavior. Thus, among the 
genes encoding proteins involved in the serotonergic 
neurotransmission in suicidal persons, the most 
consistent scientific evidences are referring to the 
tryptophan hydroxylase gene, especially in the case of 
violent suicidal behavior [28]. In addition, promising 
studies have examined the serotonin receptors, 
monoamin oxidase receptors, serotonin 2a and 2c 
receptors, and tyrosine hydroxylase.
Thus, the genetic factors seem to be a significant risk 
factor, apart from the environmental aspects of suicidal 
behavior. Moreover, epidemiological and genetic 
studies indicated a familial aggregation of suicidal 
behavior, with a fivefold greater risk for relatives of 
persons with suicidal behavior [29, 30]. In this way, 
Voracek et al. [27] reported a significantly higher rate 
of concordance for suicidal behavior in monozygotic 
twins (24.1%), as compared to dizygotic ones (2.8%).
Also, the neurobiological and genetic studies 
have suggested that, generally, the suicidal behavior 
results from a complex interaction of multiple genes 
and environmental factors. The suicide attempts in 
this suicidal model are considered a combination of 
stressors and personality traits. Basically, for this 
model, the innate genotypic and phenotypic profile of 
the individuals determines their inability to cope with 
stressors [31]. Also, many specific genetic variants 
may exert additive effects on suicidal behavior by 
intensifying the impact of a stressor. 
The researchers who analyzed the importance of 
genes in suicide have primarily focused on the genes 
involved in the serotonergic, adrenergic, noradrenergic, 
and dopaminergic neurotransmitter systems by the 
analysis of the samples taken from postmortem brain 
tissues of persons who completed suicide. Thus, 
a strong evidence supporting the association with 
suicidal attempts was identified for one of the most 
commonly studied suicide gene, the S allele of the 
serotonin transporter, but this was not found with 
respect to completed suicide [31]. Moreover, a study 
published in 2007 on bipolar patients highlighted 
the importance of the 2p12 locus in the patients with 
suicidal attempts, supporting previous studies on the 
relevance of this locus to suicidal behavior [32].
Also, the results of some studies have suggested the 
involvement of the dopaminergic system, in particular 
of the D2 receptor, in the expression of suicidal 
behavior. Thus, a study on 120 patients with suicidal 
attempts assessed the association between these 
attempts and two types of functional polymorphisms 
of the dopamine D2 receptor gene (DRD2), TaqIA 
and 141C, as compared with the control group. It 
was demonstrated [33] that there are significant 
differences of the frequency of the allele-141C Ins/
Del and TaqIA polymorphisms between patients and 
the healthy control group, suggesting that DRD2 gene 
polymorphisms might be involved in the biological 
susceptibility to suicidal behavior.
Also, cholecystokinin (CCK) could play a significant 
role in suicidal behavior. In this way, Shindo et al. [34] 
found a strong association between the gene for CCK 
(the latter as a central nervous system neurotransmitter 
found inside certain dopaminergic neurons and also 
modulating dopamine release) and suicidal behavior, 
by analyzing the DNA of 154 suicide victims, as 
compared with 328 control subjects. The statistical 
analysis demonstrated an association between the 
polymorphism of CCK ­196G/A and suicide occurance 
only in men of the studied group, and not in women.
OXYTOCIN RELEVANCE
As we mentioned at different other occasions [45], 
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within the last few years there was an increase in the 
number of research groups and general interest for 
better understanding of the possible beneficial effects 
exerted especially by intranasal oxytocin on the main 
neuropsychiatric diseases, with a focus on schizophre-
nia [54], depression [55], frontotemporal dementia 
[56], autism [57], or anxiety-related behavior [58].
In relation to suicidal behavior, there are also some 
interesting and controversial aspects to be mentioned 
for the possible influence exerted by oxytocin.
These possible correlations basically started in a 
study performed in 2009 by the Lee et al. group [59], 
which mainly focused on the relations between CSF 
oxytocin, aggression, and personality disorder, but also 
did manage to increase awareness on possible relations 
between oxytocin and suicidal behavior through only 
4 patients with suicide attempts vs. 54 controls (non-
suicidal attempters) by using the specific LHA scale.
One of the most important studies in this research 
area regarding the interactions between oxytocin 
and suicide was performed in 2012 by the Swedish 
group of Jokinen et al. [60], who clearly demonstrated 
decreased levels of oxytocin in the CSF obtained 
by lumbar punctures of 28 medication-free suicide 
attempters vs. healthy controls [60]. Moreover, the 
aforementioned group did manage to find some 
important correlations between most of the specific 
scales they have used to asses suicidal behavior (e.g., 
the Beck Suicide Intent Scale, the Freeman scale, 
or the Karolinska Interpersonal Violence Scale) and 
both CSF and plasma oxytocin levels, but only in men 
and not in women. However, the authors also found 
correlations between aggressive/violent behavior and 
oxytocin levels only in female suicide attempters (we 
would like to insist immediately on the relevance of 
this aspect). In fact, our research group also described 
earlier the complex interaction between aggressive 
behavior and oxytocin activities [45].
On the other hand, there are still controversies 
in this area of research, since some research groups 
failed to find any correlations between the oxytocin 
levels and psychiatric patients with and without recent 
suicide attempts. For example, this was the Deisen-
hammer et al. group [61], which found no differences 
in terms of plasma oxytocin concentrations between 
people with affective disorders and suicide attempts 
within the last 12 months vs. people with affective dis-
orders but no suicide attempts.
Dissimilar results obtained by various research 
groups could be explained by differences in the estab-
lished research protocol (e.g., oxytocin levels could be 
quite different in the CSF vs. plasma, as was in the two 
studies mentioned above), different medication, or the 
fact that suicidal behavior can exhibit extremely im-
portant gender differences [60, 62].
Mechanistically speaking, the implications of 
oxytocin in suicidal behavior could also be explained 
through the important effects exerted by oxytocin in 
stress modulation, e.g., by decreasing cortisol levels. 
This could be done by inhibiting the HPA axis [63].
Important correlative results between the decreased 
levels of plasma oxytocin and borderline personality 
disorder were also observed only in women patients 
[65]. This could be quite relevant in the present 
context, especially considering that certain behaviors, 
such as self-injury, suicidal, or parasuicidal one, are 
for a long time accepted in patients suffering from 
borderline personality disorder [65]. In addition, 
the aforementioned Bertsch group [64] showed 
correlations between traumatic childhood experiences 
(e.g., emotional neglect or abuse and aggressive 
behavior) and oxytocin concentrations in the plasma.
In fact, in direct relation to the traumatic childhood 
experiences, the group of Chatzittofis [66] quite 
recently (in 2014) showed that there is also an 
interesting relationship between the CSF/plasma 
oxytocin concentrations in suicide attempters and the 
role of a childhood trauma and revictimization. In this 
way, in 28 medication-free suicide attempters, these 
authors, using evaluation scales (such as the Karolinska 
Interpersonal Violence Scale), showed important 
correlations between revictimized suicide attempters 
and plasma oxytocin levels. Still, the authors failed 
to find any correlation between interpersonal violence 
exposure as a child vs. CSF and/or plasma oxytocin 
[66]. However, it is generally accepted in the literature 
that a strong correlation between childhood abuse and 
oxytocin concentration should exist [67].
Recent studies also described important interactions 
between CSF oxytocin concentrations and the 
schizophrenic pathology, especially in men [68]. This 
could be extremely relevant, especially considering 
the very well known and extensively accepted 
relationship between schizophrenia and suicidal 
behavior [69]. Anyway, the schizophrenic pathology 
has attracted an increased interest from the most 
important worldwide names in the effects of intranasal 
oxytocin studies, as, e.g., from the group of Guastella 
et al. [72]. These authors showed that only one dose of 
oxytocin nasal spray could facilitate social cognition 
in schizophrenia [54]. Still, there are controversies 
also in this area of research with previous reports 
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stating significant correlations [70] or no correlations 
at all [71] between the CSF levels of oxytocin and 
schizophrenic pathology. One of the explanations for 
this aspect could be represented by a complex nature 
of the reactions, existing between administration 
of antipsychotics in schizophrenia and the oxytocin 
concentration (e.g., they might actually decrease the 
levels of oxytocin [72]).
* * *
In our paper we, besides describing the main 
introductory aspects for the concept of suicide, 
focused our attention on the main biological and 
genetical mechanisms relevant for the suicidal 
behavior. Moreover, considering the latest interests 
in the current literature on the relevance of central 
oxytocin in various superior cognitive behaviors, we 
also desribed how important oxytocin could be in the 
context of suicidal behavior.
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Р е з ю м е
Суїцидальна поведінка – це дії, в результаті яких особа на-
магається позбавити себе життя, усвідомлюючи наслідки 
таких дій. У даному огляді, окрім опису основних загаль-
них аспектів концепції суїциду, ми концентрували увагу на 
основних нейрофізіологічних та генетичних аспектах, котрі 
мають відношення до цього вкрай важко контрольованого та 
повного протиріч типу поведінки. Окрім того, враховуючи 
велику цікавість, яку викликає в сучасній літературі заді-
яність центральної окситоцинової системи в контроль ког-
нітивної поведінки вищих типів, ми надали короткий опис 
того, наскільки ефекти окситоцину можуть бути важливими 
в контексті суїцидальної поведінки.  
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